Akari Therapeutics Stock (NASDAQ: AKTX) stock price, news, charts, stock research, profile.
You can purchase shares of Akari Therapeutics (NASDAQ:AKTX) through any online brokerage.
Other companies in Akari Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), Curis (NASDAQ:CRIS) and Barinthus Biotherapeutics (NASDAQ:BRNS).
Akari Therapeutics has a consensus price target of $2.75.
The stock price for Akari Therapeutics (NASDAQ: AKTX) is $1.2587 last updated November 21, 2024 at 6:33 PM EST.
There are no upcoming dividends for Akari Therapeutics.
Akari Therapeutics’s Q4 earnings are confirmed for Saturday, February 15, 2025.
There is no upcoming split for Akari Therapeutics.
Akari Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.